Cargando…
A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
Mefloquine (originally marketed as Lariam) is a neurotoxic quinoline derivative antimalarial drug that is known to cause serious and potentially lasting neuropsychiatric adverse reactions. Since 2013, drug regulators in several jurisdictions, including the United States, the United Kingdom, Ireland,...
Autor principal: | Nevin, Remington L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684859/ https://www.ncbi.nlm.nih.gov/pubmed/28805982 http://dx.doi.org/10.1002/prp2.328 |
Ejemplares similares
-
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data
por: Nevin, Remington L., et al.
Publicado: (2017) -
Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021) -
Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018) -
Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada
por: Nevin, Remington L., et al.
Publicado: (2016) -
A Case of Serious Adverse Reaction Following Rabies Vaccination
por: Kang, Zhilin, et al.
Publicado: (2018)